Risultati della ricerca - Sandeep Sehdev

Is It Time to Commit to a Process to Re-Evaluate Oncology Drugs? A Descriptive Analysis of Systemic Therapies for Solid Tumour Indications Reviewed in Canada from 2017 to 2021 di Sandeep Sehdev, Alexandra Chambers

Testo

Impact of Systemic Delays for Patient Access to Oncology Drugs on Clinical, Economic, and Quality of Life Outcomes in Canada: A Call to Action di Sandeep Sehdev, Joanna Gotfrit, Martine Elias, Barry D. Stein

Testo

Access Denied? The Unintended Consequences of Pending Drug Pricing Rules di Alan Kaplan, David J. Stewart, Gerald Batist, Silvana Spadafora, Sandeep Sehdev, Shaun G. Goodman

Testo

Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic di Tabitha Tse, Sandeep Sehdev, Jean Seely, Denis H. Gravel, Mark Clemons, Erin Cordeiro, Angel Arnaout

Testo

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain di Daniel Rayson, Sonal Gandhi, Anil A. Joy, Christine Brezden-Masley, Karen A. Gelmon, Sandeep Sehdev, David Cescon, Stephen Chia

Testo

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Canc... di Daniel Rayson, Sonal Gandhi, Anil A. Joy, Christine Brezden-Masley, Karen A. Gelmon, Sandeep Sehdev, David Cescon, Stephen Chia

Testo

HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review di Katarzyna J. Jerzak, Nathaniel Bouganim, Christine Brezden-Masley, Scott Edwards, Karen Gelmon, Jan-Willem Henning, John F. Hilton, Sandeep Sehdev

Testo

Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada di Katarzyna J. Jerzak, Sandeep Sehdev, Jean-François Boileau, Christine Brezden-Masley, Nadia Califaretti, Scott Edwards, Jenn Gordon, Jan-Willem Henning, Nathalie LeVasseur, Cindy Railton

Testo

Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to Action di Evan Weber, Carlos A. Carmona-Gonzalez, Melanie Boucher, Andrea Eisen, Kara Laing, Jennifer Melvin, Kasmintan A. Schrader, Sandeep Sehdev, Stephanie M. Wong, Karen A. Gelmon

Testo

New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices di David J. Stewart, John-Peter Bradford, Sandeep Sehdev, Tim Ramsay, Vishal Navani, Nigel S. B. Rawson, Di Maria Jiang, Joanna Gotfrit, Paul Wheatley-Price, Geoffrey Liu, Alan Kaplan, Silvana Spadafora, Shaun G. Goodman, Rebecca A. C. Auer, Gerald Batist

Testo

Correction to: Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Pa... di Kim A. Papp, Barbara Melosky, Sandeep Sehdev, Sebastien J. Hotte, Jennifer R. Beecker, Mark G. Kirchhof, Irina Turchin, Jan P. Dutz, Melinda J. Gooderham, Robert Gniadecki, Chih-ho Hong, Jo Lambert, Charles W. Lynde, Vimal H. Prajapati, Ronald B. Vender

Testo

A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer di Sharon F. McGee, Mark Clemons, Gregory Pond, Jean-Michel Caudrelier, Michelle Liu, Mashari Jemaan Alzahrani, Terry L. Ng, Arif A. Awan, Sandeep Sehdev, John Hilton, Marie-France Savard, Lesley Fallowfield, Vikaash Kumar, Orit Freedman, Lisa Vandermeer, Brian Hutton, Jean-Marc Bourque

Testo

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer di Jeffrey Q. Cao, Brae Surgeoner, Mita Manna, Jean-François Boileau, Karen A. Gelmon, Muriel Brackstone, Christine Brezden-Masley, Katarzyna J. Jerzak, Ipshita Prakash, Sandeep Sehdev, Stephanie M. Wong, Nathaniel Bouganim, David W. Cescon, Stephen Chia, Ian S. Dayes, Anil Abraham Joy, Jan-Willem Henning

Testo

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2− Early Breast Cancer 2025 di Sandeep Sehdev, Anil Abraham Joy, Jean-François Boileau, Nathaniel Bouganim, Christine Brezden-Masley, Jeffrey Q. Cao, David W. Cescon, Stephen Chia, Scott Edwards, Karen A. Gelmon, Katarzyna J. Jerzak, Aalok Kumar, Kara Laing, Nathalie LeVasseur, Christine Simmons, Marc Webster, Mita Manna, on behalf of Patient Advocacy, Breast Cancer Canada

Testo

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Se... di Aalok Kumar, Katarzyna J. Jerzak, Karen A. Gelmon, Jean-François Boileau, Nathaniel Bouganim, Christine Brezden-Masley, Jeffrey Q. Cao, David W. Cescon, Stephen Chia, Scott Edwards, Anil Abraham Joy, Kara Laing, Nathalie LeVasseur, Sandeep Sehdev, Christine Simmons, Marc Webster, Mita Manna, on behalf of Patient Advocacy, Breast Cancer Canada

Testo

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Se... di Mita Manna, Karen A. Gelmon, Jean-François Boileau, Christine Brezden-Masley, Jeffrey Q. Cao, Katarzyna J. Jerzak, Ipshita Prakash, Sandeep Sehdev, Christine Simmons, Nathaniel Bouganim, Muriel Brackstone, David W. Cescon, Stephen Chia, Ian S. Dayes, Scott Edwards, John Hilton, Anil Abraham Joy, Kara Laing, Marc Webster, Jan-Willem Henning

Testo

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Met... di Christine Simmons, Omar F. Khan, Christine Brezden-Masley, David W. Cescon, Anil Abraham Joy, Nathalie LeVasseur, Katarzyna J. Jerzak, Karen A. Gelmon, Sandeep Sehdev, Stephen Chia, Marc Webster, Scott Edwards, Aalok Kumar, Jeffrey Q. Cao, Jean-François Boileau, Kara Laing, Nathaniel Bouganim, Mita Manna, on behalf of Patient Advocacy, Breast Cancer Canada

Testo

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2− Metastatic Breast Cancer 2025 di Katarzyna J. Jerzak, Aalok Kumar, Jean-François Boileau, Nathaniel Bouganim, Christine Brezden-Masley, Jeffrey Q. Cao, David W. Cescon, Stephen Chia, Scott Edwards, Anil Abraham Joy, Kara Laing, Nathalie LeVasseur, Sasha Lupichuk, Sandeep Sehdev, Christine Simmons, Marc Webster, Karen A. Gelmon, Mita Manna, on behalf of patient advocacy, Breast Cancer Canada

Testo